Compare OCUL & DNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCUL | DNP |
|---|---|---|
| Founded | 2006 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | 2014 | N/A |
| Metric | OCUL | DNP |
|---|---|---|
| Price | $11.41 | $10.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $22.56 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 479.6K |
| Earning Date | 03-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.30 |
| Revenue | $55,783,000.00 | ★ $154,887,179.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.96 | N/A |
| P/E Ratio | ★ N/A | $4.26 |
| Revenue Growth | N/A | ★ 3.30 |
| 52 Week Low | $5.79 | $8.69 |
| 52 Week High | $16.44 | $10.04 |
| Indicator | OCUL | DNP |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 52.26 |
| Support Level | $10.77 | $9.99 |
| Resistance Level | $13.03 | $10.06 |
| Average True Range (ATR) | 0.77 | 0.10 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 48.37 | 78.57 |
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.